Israel Englander Agios Pharmaceuticals, Inc. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding AGIO
# of Institutions
235Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$210 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$177 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$131 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$84.7 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...